Literature DB >> 3037115

Rous sarcoma virus mutant dlPA105 induces different transformed phenotypes in quail embryonic fibroblasts and neuroretina cells.

F Poirier, D Laugier, M Marx, G Dambrine, E A Garber, P Genvrin, T David-Pfeuty, G Calothy.   

Abstract

dlPA105 is a spontaneous variant of Rous sarcoma virus, subgroup E, which carries a deletion in the N-terminal portion of the v-src gene coding sequence. This virus was isolated on the basis of its ability to induce proliferation of quiescent quail neuroretina cells. The altered v-src gene encodes a phosphoprotein of 45,000 daltons which possesses tyrosine kinase activity. DNA sequencing of the mutant v-src gene has shown that deletion extends from amino acid 33 to 126 of wild-type p60v-src. We investigated the tumorigenic and transforming properties of this mutant virus. dlPA105 induced fibrosarcomas in quails with an incidence identical to that induced by wild-type virus. Quail neuroretina cells infected with the mutant virus were morphologically transformed and formed colonies in soft agar. In contrast, dlPA105 induced only limited morphological alterations in quail fibroblasts and was defective in promoting anchorage-independent growth of these cells. Synthesis and tyrosine kinase activity of the mutant p45v-src were similar in both cell types. These data indicate that the portion of the v-src protein deleted in p45v-src is dispensable for the mitogenic and tumorigenic properties of wild-type p60v-src, whereas it is required for in vitro transformation of fibroblasts. The ability of dlPA105 to induce different transformation phenotypes in quail fibroblasts and quail neuroretina cells is a property unique to this Rous sarcoma virus mutant and provides evidence for the existence of cell-type-specific response to v-src proteins.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3037115      PMCID: PMC255687          DOI: 10.1128/JVI.61.8.2530-2539.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  A transformation defective mutant of Rous sarcoma virus inducing chick embryo neuroretinal cell proliferation.

Authors:  G Calothy; F Poirier; G Dambrine; B Pessac
Journal:  Virology       Date:  1978-08       Impact factor: 3.616

2.  The absence of myristic acid decreases membrane binding of p60src but does not affect tyrosine protein kinase activity.

Authors:  J E Buss; M P Kamps; K Gould; B M Sefton
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

3.  Functional domains of the pp60v-src protein as revealed by analysis of temperature-sensitive Rous sarcoma virus mutants.

Authors:  A W Stoker; P J Enrietto; J A Wyke
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

Review 4.  Subcellular localization of pp60src in RSV-transformed cells.

Authors:  J G Krueger; E A Garber; A R Goldberg
Journal:  Curr Top Microbiol Immunol       Date:  1983       Impact factor: 4.291

5.  Fine structural mapping of a critical NH2-terminal region of p60src.

Authors:  D Pellman; E A Garber; F R Cross; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

6.  Interaction between the Rous sarcoma virus transforming protein and two cellular phosphoproteins: analysis of the turnover and distribution of this complex.

Authors:  J Brugge; W Yonemoto; D Darrow
Journal:  Mol Cell Biol       Date:  1983-01       Impact factor: 4.272

7.  A short sequence in the p60src N terminus is required for p60src myristylation and membrane association and for cell transformation.

Authors:  F R Cross; E A Garber; D Pellman; H Hanafusa
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

8.  An N-terminal peptide from p60src can direct myristylation and plasma membrane localization when fused to heterologous proteins.

Authors:  D Pellman; E A Garber; F R Cross; H Hanafusa
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

9.  Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation.

Authors:  M P Kamps; J E Buss; B M Sefton
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

10.  Role of the mitogenic property and kinase activity of p60src in tumor formation by Rous sarcoma virus.

Authors:  F Poirier; P Jullien; P Dezelee; G Dambrine; E Esnault; A Benatre; G Calothy
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

View more
  4 in total

1.  N-terminal deletion in the src gene of Rous sarcoma virus results in synthesis of a 45,000-Mr protein with mitogenic activity.

Authors:  D Laugier; M Marx; J V Barnier; F Poirier; P Genvrin; P Dezélée; G Calothy
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

2.  Transformed and tumorigenic phenotypes induced by avian retroviruses containing the v-mil oncogene.

Authors:  C Béchade; G Dambrine; T David-Pfeuty; E Esnault; G Calothy
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

3.  Transformation of chicken embryo fibroblast cells by avian retroviruses containing the human Fyn gene and its mutated genes.

Authors:  K Semba; S Kawai; Y Matsuzawa; Y Yamanashi; M Nishizawa; K Toyoshima
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

4.  N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl.

Authors:  P Jackson; D Baltimore
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.